Imexpharm

Outlook for pharmaceutical stocks in 2024

April 22, 2024 | 08:00

At a macro level in which there is still complexity, the pharmaceutical industry is expected to continue witnessing positive business results in 2024.

Imexpharm set growth record in 2023

April 02, 2024 | 08:00

Imexpharm Corporation announced its business results on March 27, for the fiscal year ending December 31, 2023.

Imexpharm joins Vietnam's campaign to plant one billion trees

March 22, 2024 | 14:04

Imexpharm Pharmaceutical JSC (IMP) teamed up with Nha Trang People's Committee to plant 500 trees along Ring Road 2 on March 18.

Imexpharm forges partnership with Genuone Sciences

February 27, 2024 | 11:16

IMP has signed a strategic cooperation agreement with Genuone Sciences Inc.

Domestic pharmaceutical products anticipate 2024 boost

January 23, 2024 | 10:15

Despite a challenging 2023, the pharmaceutical industry remains healthy thanks to the breakthroughs of leading pharmaceutical companies.

Imexpharm clinches top honours in corporate annual reporting

December 28, 2023 | 14:18

Imexpharm has scored top honours in corporate governance.

SK Investment Vina III to hold 65 per cent of Imexpharm

December 28, 2023 | 11:20

SK Investment Vina III, a subsidiary of South Korea’s third-largest conglomerate SK Group, is looking to acquire a 65 per cent stake in Imexpharm Pharmaceutical.

Imexpharm honoured as top 5 company with best working environment in Vietnam

November 30, 2023 | 14:05

Imexpharm Pharmaceutical has been named in the top 5 companies with the best working environment in Vietnam.

Imexpharm raises its status with EU-GMP-standard factories

November 25, 2023 | 17:38

With the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become an industry leader.

Imexpharm making inroads in achieving sustainable efficiency

March 01, 2022 | 18:00

After four decades of development, Imexpharm Corporation has reaffirmed its position as a market leader in Vietnam’s pharmaceutical industry by investing in sustainable technology and human resources.

Imexpharm Corporation reports dropping revenue during social distancing

September 23, 2021 | 08:00

In August, Imexpharm Corporation recognised a decrease of 12 per cent in revenue and 14 per cent in profit due to social distancing.

SK Investment Vina raises ownership to 29.2 per cent in Imexpharm

June 15, 2021 | 20:43

SK Investment Vina III Pte., Ltd. has acquired 3.4 million shares of Imexpharm Pharmaceutical JSC to raise its ownership at the firm to 29.22 per cent.

Imexpharm secures loan from ADB to support generic medicine production

December 16, 2020 | 11:55

The ADB signed an $8 million loan to help Imexpharm sustain the production of generic medicines, despite global supply disruptions caused by COVID-19.

SK Group acquires 25 per cent of Imexpharm

June 01, 2020 | 14:44

South Korean conglomerate SK Group has acquired a quarter interest in Imexpharm, adding to its considerable portfolio of shares in Vingroup, Masan, and PV Oil.